Immunome, Inc. (IMNM) Operating cash flow 2019–2025
Immunome, Inc. (IMNM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$190.9MFY2025 · since FY2019: -$9.6M → -$190.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.9M | -72.3% |
| FY2024 | -$110.8M | -1364.0% |
| FY2023 | -$7.6M | +73.6% |
| FY2022 | -$28.7M | -57.4% |
| FY2021 | -$18.2M | -50.2% |
| FY2020 | -$12.1M | -26.4% |
| FY2019 | -$9.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice